Stock Markets

Mar. 30, 2026

Needham & Company Reaffirms Buy Rating for Boston Scientific

Research firm maintains price target of $97 on medical device maker's stock

Mar. 30, 2026

SELLAS Life Sciences Group Stock Price Drops 7.7%

Shares of the biotech company fall amid market volatility

Mar. 29, 2026

Short Interest in ClearPoint Neuro Surges 29% in March

Approximately 15.4% of the company's stock are currently sold short

Mar. 29, 2026

CIBRA Capital Ltd Acquires Stake in Hologic, Inc.

Investment firm adds 62,838 shares of medical equipment provider to portfolio

Mar. 29, 2026

Sarepta Therapeutics Price Target Raised to $13

Citigroup boosts price target on biotech firm's stock despite recent earnings miss

Mar. 29, 2026

Nordea Investment Management Boosts Stake in Akebia Therapeutics

The investment firm acquired over 750,000 shares of the biopharmaceutical company in Q4 2025.

Mar. 29, 2026

JPMorgan Chase Reduces Stake in Sensata Technologies

Financial giant cuts position in scientific instruments company by 14.7%

Mar. 29, 2026

Short Interest in MFS Multimarket Income Trust Surges 43.8%

The closed-end fund's short interest ratio now stands at 1.3 days.

Mar. 28, 2026

MariMed Sees Significant Drop in Short Interest

Cannabis company's short interest declines by over 40% in March

Mar. 28, 2026

Shattuck Labs Upgraded to Buy Rating by Wall Street Firm

Analysts see growth potential for biotech company's opioid addiction treatment pipeline

Mar. 28, 2026

Nordea Trims Biogen Stake by 89%

Investment firm reduces holdings in biotech company during Q4 2025

Mar. 28, 2026

Celsius Holdings Sees Surge in Short Interest

Short positions on the energy drink maker's stock rise over 40% in March

Mar. 28, 2026

Amylyx Pharmaceuticals' (AMLX) 'Buy' Rating Reiterated at HC Wainwright

Analysts maintain positive outlook on biotech firm's lead drug candidate

Mar. 27, 2026

Precision Optics Corporation Announces $10M Public Stock Offering

The oversubscribed offering was led by a mix of existing and new institutional investors.

Mar. 27, 2026

Boston Beer Stock Crosses 200-Day Average

Analysts weigh in on what's next for the craft brewing company's shares.

Mar. 27, 2026

Riverbridge Partners Reduces Repligen Corporation Stake

Institutional investor sells 30,070 shares of biotech company's stock

Mar. 27, 2026

Stableford Capital II LLC Acquires New Shares in Biogen Inc.

Biotechnology firm sees new institutional investor take stake

Mar. 27, 2026

Baker Chad R Sells 8,990 Shares of Vertex Pharmaceuticals

Insider selling activity at the pharmaceutical company

Mar. 27, 2026

Biogen Receives $205.31 Average Price Target from Analysts

Biogen stock assigned 'Hold' rating by 28 brokerages covering the company

Mar. 27, 2026

PureTech Health Shares Drop 3.1%

Is it time to sell the biopharmaceutical company's stock?